Analytical profile of moxidectin

Moxidectin or F28249α is a potent endectocide and semisynthetic methoxime derivative of naturally occurring nemadectin. It is well known for the novel mode of action against a broad range of nematode and anthropod animal parasites. In this work, physicochemical and pharmaceutical aspects of moxidectin are described including stability, semisynthesis, purification processes, formulation compositions, impurities, and degradation pathways. Additional experiments such as DSC, XRD, and CHN analysis were carried out to complete the profile of moxidectin. The importance of safety and quality of drug substances was highlighted by chronological developments involving moxidectin and its analogues. The information gathered from the literature was used to trace the origins of moxidectin-related substances presented in the European Pharmacopeia (EP) compendial monograph. During the review, it was noticed that majority of impurities presented in the EP does not have any potential to increase with time in drug substance or formulated products; therefore, they do not require monitoring during stability studies. This also showed the requirement for further characterization of the impurities observed during long-term storage and development of stability indicating methods distinguishing between process impurities and the true degradation products. Furthermore, the stability of moxidectin in formulations is also reviewed in conjunction with known degradation routes and innovative ways to formulate products that are stable and effective at intended shelf life.

Fast separation liquid chromatography-tandem mass spectrometry for the confirmation and quantitative analysis of avermectin residues in food

A new residue analytical method for the confirmation and quantification of avermectin residues in food is described in this article. This method allows a fast analysis for the determination of avermectin residues, abamectin (ABM), ivermectin (IVM), emamectin benzoate (EMA) and doramectin (DOR) by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Separation was performed using a short column of 1.8 microm particle size. The hybrid quadrupole/linear ion trap (QqQ(LIT)) system via the linearly accelerating (LINAC) high-pressure collision cell, allows the MS detection in multiple reaction monitoring (MRM) mode operating in fast scan acquisition times. The effect of reduced dwell times on mass spectral quality and sensitivity is evaluated in this study. For quantitative purposes, the influence of dwell time on S/N ratio and peak area was observed. ABM, IVM, EMA and DOR show an increased trend of peak area and S/N ratio, when dwell times are of 50 ms against 10-20 ms, suited when the number of compounds to be analyzed is higher. The sensitivity achieved by using the LC-MS/MS system is enough for the confirmation of avermectin residues in the selected commodities (salmon muscle and pepper) at trace concentration levels (sub-microg/kg and microg/kg) and therefore a sample pre-concentration step was not necessary. The instrumental limits of quantification (ILQ) are in the range of 0.15-5 ppb. Samples were extracted by solid-liquid extraction (SLE) procedure using acetonitrile, and cleaned-up using alumina. The average recoveries obtained were acceptable (80-95%). The calibration curves were linear over the working range from ILQs to 500 microg/kg. For the quantitative analysis, matrix-matched calibration and dilution of SLE extracts was proven as reliable alternative to compensate matrix-effects and for its feasible application in routine analysis.

Positive and negative electrospray LC-MS-MS methods for quantitation of the antiparasitic endectocide drugs, abamectin, doramectin, emamectin, eprinomectin, ivermectin, moxidectin and selamectin in milk

Avermectin endectocides are used for the treatment of cattle against a variety of nematode and arthropod parasites, and consequently may appear in milk after normal or off-label use. The compounds abamectin, doramectin, and ivermectin, contain only C, H and O and may be expected to be detected by LC-MS in negative ion mode. The others contain nitrogen in addition and would be expected to be preferentially ionized in positive mode. The use of positive ion and negative ion methods with electrospray LC-MS-MS were compared. Using negative ion the compounds abamectin, doramectin, ivermectin, emamectin, eprinomectin, and moxidectin gave a curvilinear response and were quantified in raw milk by LC-MS-MS with a triethylamine-acetonitrile buffer over the concentration range 1-60 ppb (microg/kg) using selamectin as the internal standard. The limits of detection (LOD) were between 0.19 ppb (doramectin) and 0.38 ppb (emamectin). The compounds gave maximum sensitivity with positive ionisation from a formic acid-ammonium formate-acetonitrile buffer and were detected in milk (LC-MS-MS) also with a curvilinear response over the range 0.5-60 ppb. Although the positive ion signals were larger, with somewhat lower limits of detection (LOD between 0.06 ppb (doramectin) and 0.32 ppb (moxidectin) the negative ion procedure gave a more linear response and more consistent results. Comparison of spiked samples in the range 2-50 ppb showed a high degree of correlation between the two methods.

Analysis of Moxidectin by LC/MS and Determination of Residues in Adipose and Muscle Tissues in Commercial Beef

We have analyzed moxidectin residues in beef by a rapid and highly sensitive liquid chromatography-mass spectrometry (LC/MS) method without fluorescent derivatization. By using atmospheric pressure chemical ionization (APCI) with a fragment voltage of 100 V, good measurement results were obtained and the recoveries of moxidectin were 93.3% and 96.5% from adipose and muscle tissues, respectively. Identification of moxidectin residues in commercial beef was performed using three monitor ions. When quantitated at m/z 622, the levels of moxidectin were 35 ng/g in adipose tissue and 4.3 ng/g in muscle tissue. After adjustment for fat content and calculation of the moxidectin concentration on a fat basis, it was found that the moxidectin contents were the same in adipose and muscle tissues. Thus, it is considered that residual levels of moxidectin in adipose and muscle tissues are correlated to the fat contents in the tissues.

Determination of ivermectin B(1a) in animal plasma by liquid chromatography combined with electrospray ionization mass spectrometry

A novel, sensitive and specific method for the quantitative determination of ivermectin B(1a) in animal plasma using liquid chromatography combined with positive electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) is presented. Abamectin was used as the internal standard. Extraction of the samples was performed with a deproteinization step using acetonitrile. Chromatographic separation was achieved on a Nucleosil ODS 5 microm column, using gradient elution with 0.2% (v/v) acetic acid in water and 0.2% (v/v) acetic acid in acetonitrile. The method was validated according to the requirements defined by the European Community. Calibration curves using plasma fortified between 1 and 100 ng ml(-1) showed a good linear correlation (r > or = 0.9989, goodness-of-fit coefficient < or =8.1%). The trueness at 2 and 25 ng ml(-1) (n = 6) was +4.2 and -17.1%, respectively. The trueness and between-run precision for the analysis of quality control samples at 25 ng ml(-1) was -4.0 and 11.0%, respectively (n = 16). The limit of quantification of the method was 1.0 ng ml(-1), for which the trueness and precision also fell within acceptable limits. Using a signal-to-noise ratio of 3 : 1, the limit of detection was calculated to be 0.2 ng ml(-1). The specificity was demonstrated with respect to ivermectin B(1b). The method was successfully used for the quantitative determination of ivermectin B(1a) in plasma samples from treated bovines, demonstrating the usefulness of the developed method for application in the field of pharmacokinetics.

Confirmation of avermectin residues in food matrices with negative-ion atmospheric pressure chemical ionization liquid chromatography/mass spectrometry

A multi-residue LC/MS method has been developed to confirm avermectin drug residues in several food matrices. Ivermectin (IVR), doramectin (DOR), eprinomectin (EPR) and moxidectin (MOX) are confirmed using atmospheric pressure chemical ionization (APCI) with negative ion detection and selected ion monitoring of three to four ions for each compound. The drug residues are extracted from tissue or milk using previously published procedures. IVR and DOR are confirmed at 20 ppb levels in fortified salmon muscle; IVR is also confirmed in tissue from salmon dosed with the drug. Residues of DOR, IVR, and EPR are confirmed in fortified milk at the 20 ppb level and in fortified beef liver at 40 ppb. Residues of MOX can also be confirmed in these matrices, but at slightly higher levels (40-80 ppb).